Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups.
about
Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonistsImmunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationshipReverse thioether ligation route to multimeric peptide antigens.TLR-based immune adjuvants.Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesA modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building.Characterization of a branched lipopeptide candidate vaccine against influenza A/Puerto Rico 8/34 which is recognized by human B and T-cell immune responses.Synthesis and characterisation of self-assembled and self-adjuvanting asymmetric multi-epitope lipopeptides of ovalbumin.Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide.A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infectionDifferential Responses of Pattern Recognition Receptors to Outer Membrane Vesicles of Three Periodontal PathogensModern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products.The use of plants for the production of therapeutic human peptides.Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships.Challenges and solutions for a rational vaccine design for TB-endemic regions.Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact.Advances in Antiviral Therapies Targeting Toll-like Receptors.Investigation of structure-activity relationships of synthetic anti-gonadotropin releasing hormone vaccine candidates.Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.Differential outcomes of TLR2 engagement in inflammation-induced preterm birth.Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide.Prospects on the Use of sp. to Develop Oral Vaccines
P2860
Q33721641-07C8A8EB-CDC4-4F09-8043-6D85AF7BB82BQ34131142-EECC8D43-0CDE-4A19-9A3F-609300511095Q34190774-9D374541-BE78-440F-831D-537134CF3FA6Q34400322-170A1119-A0C4-4553-856E-5411E67A7F8FQ34455275-0EFC07E9-B513-4D3B-B33A-453C6CED657AQ34787042-E68C7733-E816-4592-B160-7C774D307A24Q35133760-8A608BBE-B9D3-40BC-8986-5E45AA8D84BFQ35423378-6AD4EB1E-08C0-49DC-B7FE-FD4A51C5CBB6Q35886752-B8112E9C-5F28-4C79-9B62-76EBA2DFC8D3Q35920476-3B6E9792-28FF-439F-8391-5F5EFA4ABED8Q35976366-3BF7B910-D4AB-4DD0-9559-A4066B9511C6Q37661001-BA5EDFE4-38FB-44F8-A62E-AEF6F674AB85Q37973256-A5C49FA6-C277-4813-A652-2498EB6A3330Q38153040-F0DA3778-6A5F-417F-867F-0EDDC3A5A64AQ38185119-7A63E9F7-5FD8-49A8-B6C9-550DDD3C2DD8Q38279548-BDEBF709-D2E9-4D67-A7B1-C9B7B6D812D7Q38733975-1EEC6E5D-B5BD-43CE-ABD5-601D4D5ACF87Q38895112-639AB563-4D72-4415-92A4-DB67631082B9Q47590580-E31D13B4-D783-4907-97A3-9171093F24BEQ49973459-9CCD3956-BD53-41EF-A850-29305FB6CD7BQ55401761-5CA6C614-2189-4EA0-B28B-769A1F0D6825Q58556430-074C7295-45BA-4B1C-91B5-76342A0C15FC
P2860
Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Comparison of lipopeptide-base ...... aining different lipid groups.
@en
Comparison of lipopeptide-base ...... aining different lipid groups.
@nl
type
label
Comparison of lipopeptide-base ...... aining different lipid groups.
@en
Comparison of lipopeptide-base ...... aining different lipid groups.
@nl
prefLabel
Comparison of lipopeptide-base ...... aining different lipid groups.
@en
Comparison of lipopeptide-base ...... aining different lipid groups.
@nl
P1433
P1476
Comparison of lipopeptide-base ...... aining different lipid groups.
@en
P2093
Weiguang Zeng
Yuk Fai Lau
P304
P356
10.1016/J.VACCINE.2006.07.012
P407
P577
2006-07-31T00:00:00Z